Press release
Strong Growth Ahead: Liver Cancer Therapeutics Market Size To Grow At Arecord 16.8% Cagr By 2029
Liver Cancer Therapeutics
How Big Is the Liver Cancer Therapeutics Market Size Expected to Be by 2034?
The market for liver cancer treatments has seen a swift expansion in recent years. The market, presently valued at $2.52 billion in 2024, is projected to increase to $2.95 billion the following year, reflecting a compound annual growth rate (CAGR) of 17.1%. The noticeable growth in the historical period can be attributed to a rise in funding from government and non-profit organizations, a global increase in healTH*Care spending, an expanded health insurance coverage in emerging nations, an aging global demographic, and a rise in the prevalence of obesity and diabetes.
The market for liver cancer therapeutics anticipates a swift acceleration in the forTH*Coming years, swelling to a valuation of $5.50 billion by 2029 with a compound annual growth rate (CAGR) of 16.8%. This projected expansion in the forecast timeline is linked to an increasing global prevalence of liver cancer, higher incidences of Hepatitis B and C, a surge in alcohol-induced liver conditions, a growing number of non-alcoholic fatty liver disease cases, and the rising popularity of immunotherapy techniques. Key trend shifts for the forecast period include the incorporation of AI and ML in drug innovation, the employment of big data and real-world evidence in clinical trials, the advent of superior imaging technologies, the use of minimal invasive diagnostic instruments, and the implementation of telemedicine and digital health in oncology aftercare.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/customise?id=24283&type=smp
What Are the Emerging Segments Within the Liver Cancer Therapeutics Market?
The liver cancer therapeutics market covered in this report is segmented -
1) By Type: Hepatocellular Carcinoma, Cholangio Carcinoma, Hepatoblastoma, Other Types
2) By Therapy Type: Targeted Therapy, Immunotherapy, Chemotherapy, Radiation Therapy, Other Therapy Types
3) By Distribution Channel Type: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
4) By End-Users: Pediatrics, Adults
Subsegments:
1) By Hepatocellular Carcinoma: Localized Hepatocellular Carcinoma, Advanced Hepatocellular Carcinoma, Recurrent Hepatocellular Carcinoma
2) By Cholangiocarcinoma: Intrahepatic Cholangiocarcinoma, Extrahepatic Cholangiocarcinoma, Perihilar Cholangiocarcinoma
3) By Hepatoblastoma: Standard-Risk Hepatoblastoma, High-Risk Hepatoblastoma, Metastatic Hepatoblastoma
4) By Other Types: Fibrolamellar Carcinoma, Angiosarcoma Of The Liver, Hemangiosarcoma
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24283&type=smp
What Long-Term Drivers Are Shaping Liver Cancer Therapeutics Market Trends?
The escalating occurrence of hepatitis B infections is expected to drive the expansion of the liver cancer therapeutics market in the future. Hepatitis B is a viral ailment, caused by the hepatitis B virus (HBV), primarily targeting the liver and possibly leading to acute (short-term) and chronic (long-term) health issues, including liver cancer. The surge in hepatitis B infections is largely attributed to the rising use of injectable drugs, which promotes the spread of the virus through the exchange of contaminated needles and syringes. Therapeutics for liver cancer are necessary for hepatitis B infections, because chronic infection can result in ongoing liver inflammation and cellular damage, significantly escalating the odds of evolving into malign liver conditions over time. Cases in point include a report by the World Health Organization (WHO), a Switzerland-based intergovernmental organization, in April 2024, showing that there were over 254 million people globally positive with hepatitis B in 2022, and marking 1.2 million new instances. Moreover, hepatitis B accounted for 83% of the 1.3 million deaths globally associated with viral hepatitis. Therefore, the increasing incidence of hepatitis B infections will spur on the growth of the liver cancer therapeutics market.
Who Are the Top Competitors in Key Liver Cancer Therapeutics Market Segments?
Major companies operating in the liver cancer therapeutics market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Novartis AG, Bayer AG, Sanofi SA, Bristol-Myers Squibb, AstraZeneca PLC, Amgen Inc., Eli Lilly and Company , Gilead Sciences Inc., Regeneron Pharmaceuticals Inc., Eisai Co. Ltd., Ipsen, Exelixis Inc., BeiGene Ltd., Hutchmed, Celgene Corporation, Zymeworks Inc., Can-Fite BioPharma, Onyx Pharmaceuticals Inc.
What Are the Latest Developing Trends in the Liver Cancer Therapeutics Market?
In order to provide long-lasting effects, major businesses in the liver cancer therapeutics sector are concentrating their efforts on developing novel treatments like prescription immunotherapy medicines. These are drugs that boost or inhibit our immune system to help combat certain ailments, such as cancer or chronic infections, by specifically regulating immune responses. For instance, in April 2025, Bristol Myers Squibb, an American biopharmaceutical firm, unveiled the approval of Opdivo (nivolumab) and Yervoy (ipilimumab) for adult patients with hepatocellular carcinoma (HCC), the most common primary liver cancer. This approval was granted for cases that are either untreatable or have metastasized, to be used as a first-line defense. The exclusivity of this medication comes from its approval being based on the results of the worldwide Phase 3 CheckMate-9DW trial. During this trial, patients with metastatic or untreatable HCC, who had not undergone systemic therapy before, were randomly selected to receive Opdivo and Yervoy, in addition to a tyrosine kinase inhibitor monotherapy (lenvatinib or sorafenib) of the investigator's choosing. The combined therapy showed statistically noteworthy progress in overall survival (OS) and overall response rate (ORR) compared to the control group, making this the sole trial backing an FDA approval that presents superior outcomes in this condition.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/liver-cancer-therapeutics-global-market-report
Which Regions Are Becoming Hubs for Liver Cancer Therapeutics Market Innovation?
North America was the largest region in the liver cancer therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the liver cancer therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Liver Cancer Therapeutics Market?
2. What is the CAGR expected in the Liver Cancer Therapeutics Market?
3. What Are the Key Innovations Transforming the Liver Cancer Therapeutics Industry?
4. Which Region Is Leading the Liver Cancer Therapeutics Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Strong Growth Ahead: Liver Cancer Therapeutics Market Size To Grow At Arecord 16.8% Cagr By 2029 here
News-ID: 4061454 • Views: …
More Releases from The Business Research Company
Company Registration Service Market Landscape 2025: Forecast Data and Growth Str …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Company Registration Service Market Through 2025?
The market size for company registration services has seen robust growth in the recent past. The market is projected to expand from $10.67 billion in 2024 to $11.55 billion in 2025, exhibiting a compound annual growth…
Comprehensive 2025 Commercial Toilet Partition Market Overview: Trends, Forecast …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Toilet Partition Market Through 2025?
In recent years, the market size for commercial toilet partitions has significantly expanded. The forecast predicts a rise from $1.82 billion in 2024 to $1.95 billion in 2025, with a compound annual growth rate (CAGR) of…
Key Trends Influencing the Growth of the Commercial Insurance For Small And Medi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Insurance For Small And Medium-Sized Enterprises (SMEs) Market Through 2025?
The market size of commercial insurance for small and medium-sized enterprises (SMEs) has seen substantial growth over the recent years. A rise from $111.83 billion in 2024 to $119.76 billion in…
Growing Focus On Reducing Greenhouse Gas Emissions Driving The Market Growth Due …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Combustion Emissions Analyzer Market Through 2025?
In the past few years, the market size for combustion emissions analyzer has seen robust growth. It is projected to increase from $1.02 billion in 2024 to $1.09 billion in 2025, with a compound annual growth…
More Releases for Liver
Rising Liver Disease Cases Drive Growth In Liver Metastases Treatment Market Dri …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Liver Metastases Treatment Market Size By 2025?
The market for treating liver metastases has seen significant growth in the past few years. It is projected to increase from $1.57 billion in 2024 to $1.71 billion in 2025, with a compound annual growth rate (CAGR) of…
LivCare Liver Support
The liver plays a crucial role in maintaining overall well-being, performing essential functions like detoxification, digestion, and metabolism. However, many people overlook the importance of liver health until problems arise. LivCare Liver Support is a premium supplement designed to keep your liver in peak condition. By incorporating this supplement into your daily routine, you can help ensure your liver functions optimally, leading to better overall health.
● Product Name - LivCare…
Liver Cancer Therapeutics Market - Empowering Recovery, Restoring Health: Innova …
Newark, New Castle, USA - new report, titled Liver Cancer Therapeutics Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Liver Cancer Therapeutics market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Liver Cancer Therapeutics market. The report offers an overview of…
Liver Health Supplements Market Grows Strong as Consumers Adopt Proactive Measur …
Global liver health supplements market was valued at US$ 8.7 Bn in 2021, is growing at an estimated CAGR of 5.8% over the forecast period (2022 - 2030). The liver health supplements market is growing due to the increasing awareness of the importance of liver health and the rise of lifestyle-related liver diseases. The market offers a wide range of supplements that help in improving liver function, supporting liver detoxification,…
Urgent Liver 911 Reviews 2021: Is Urgent Liver 911 Legit?
Urgent Liver 911 by PhytAge Laboratories is a powerful diet that promotes liver function by combining natural minerals and nutrients. The diet is made up of plant and herbal extracts that collectively aid in liver cell protection. While the liver is an important human organ that promotes general health and vitality, most people are unaware that even those who appear to be in good health can be affected by liver…
Liver Extract Power Exporter, Liver Extract Product, Liver Extract Crude, Liver …
Titan Biotech is an ISO 9001:2000 Certified Company, established with an objective of serving Scientific Community and providing good quality of Biological Products, Biotechnology Products, Biological Extracts and their derivatives. Liver Extract Power Exporter is produced from specific fraction of beef liver. Liver Extract is rich in vital nutrients including energy producing B Vitamins and serve as an excellent source of proteins. Liver Extract is capable of stimulating the production…
